Table 3.
Summary of in vivo studies on the anti-colitis activity of arctigenin.
| Model | In vivo studies | Potential molecular mechanisms | Ref. |
|---|---|---|---|
| DSS induction | 50 mg/kg, DAI↓, MPO↓, IL-6↓, TNF-α↓, MIP-2↓, MCP-1↓, MAdCAM-1↓, ICAM-1↓, VCAM-1↓, E-selectin↓, MDA↓, SOD↑, GSH↑ | phosphorylation of p38 MAPK, ERK, JNK, IκBα and p65↓, | [64] |
| the differentiation of Th1 cells↓, IFN-γ↓, IL-17A↓, IL-17F↓, IL-21↓, IL-22↓, Th1↓, Th17↓ | phosphorylation of genes p70S6K and RPS6↓, via mTORC1 pathway | [66] | |
| TNBS induce | 30 and 60 mg/kg, TNF-α↓, IL-1β↓, IL-6↓, | PI3K↓, AKT↓, NF-κB↓ | [33] |
↓Reduce, inhibition or down-regulated.
↑Increase or up-regulated.